School of Medicine
Dermatology | Pediatrics | Skin and Connective Tissue Diseases
Gorlin syndrome (GS) is a risk factor for early basal cell carcinomas (BCCs), although its prevalence of fewer than 1 in 30,000 individuals limits existing literature. There are sparse pediatric GS studies beyond case reports, creating a knowledge gap regarding childhood cutaneous findings and sequelae, including BCC age at onset, quantity, treatments, and impact. Herein, we describe a global survey to illustrate the clinical presentation, childhood perspectives, and BCC management trends for pediatric GS to improve the understanding and inform patient care.
BCNS, Gorlin syndrome, basal cell carcinoma, basal cell nevus syndrome, pediatric
Rights and Permissions
Copyright 2021 by the American Academy of Dermatology, Inc. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
DOI of Published Version
Neale H, Breneiser JA, Hawryluk EB. Pediatric basal cell carcinoma burden and management preferences in Gorlin syndrome: A survey study. JAAD Int. 2021 Aug 17;5:49-51. doi: 10.1016/j.jdin.2021.07.003. PMID: 34816134; PMCID: PMC8593749.
Neale H, Breneiser JA, Hawryluk EB. (2021). Pediatric basal cell carcinoma burden and management preferences in Gorlin syndrome: A survey study. T.H. Chan School of Medicine Student Publications. https://doi.org/10.1016/j.jdin.2021.07.003. Retrieved from https://escholarship.umassmed.edu/som_pubs/15
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.